PMID: 6978259Mar 1, 1982Paper

Levels of colony-stimulating and inhibiting activities in chicks with myeloblastic leukemia are related to disease progression

Experimental Hematology
D L BryantW H Dodge

Abstract

Chicks with myeloblastic leukemia induced by avian myeloblastosis virus (AMV) exhibited increased levels of plasma granulocyte/monocyte (GM) colony-stimulating activity (CSA). Chromatography of plasma from AMV-infected chicks revealed that this CSA eluted in the first protein peak from a column of Sephadex G-200. A second protein peak from the same column contained an inhibitor of GM colony-formation. The presence of the inhibitor and the increased CSA was studied during the development of myeloblastic leukemia. The disease course was separated into two distinct phases: 1) an early phase characterized by the onset of viremia, the induction of leukemic colony-forming cells (CFC) in the marrow, and moderately increased marrow cellularity, 2) a late phase characterized by marked increases in the early parameters, dramatic increases in the number of myeloblasts and decreases in the number of erythrocytic cells. Induction of the GM-CFC-inhibitor occurred during the initial stages of the first phase. Increased GM-CSA occurred later in this phase. We conclude that induction of the inhibitor and increased CSA were associated with disease progression rather than ancillary characteristics of frank disease.

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.